Search research articles
Contact Us
Filters
Showing results (101-110 of 137) with videos related to
Page
of 14
Sort By:
The Journal of Pathology
|
December 17, 2021
Myeloma cells regulate miRNA transfer from fibroblast-derived exosomes by expression of lncRNAs
Ilaria Saltarella, Aurelia Lamanuzzi, Vanessa Desantis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 28, 2013
Novel targeting of phospho-cMET overcomes drug resistance and induces antitumor activity in multiple myeloma
Michele Moschetta, Antonio Basile, Arianna Ferrucci, et al.
Frontiers in Medicine
|
June 2, 2022
Cardiovascular Risk in Patients With Takayasu Arteritis Directly Correlates With Diastolic Dysfunction and Inflammatory Cell Infiltration in the Vessel Wall: A Clinical, <i>ex vivo</i> and <i>in vitro</i> Analysis
Sebastiano Cicco, Vanessa Desantis, Antonio Vacca, et al.
Blood
|
May 29, 2008
Oral melphalan, prednisone, and thalidomide in elderly patients with multiple myeloma: updated results of a randomized controlled trial
Antonio Palumbo, Sara Bringhen, Anna M Liberati, et al.
The Journal of Pathology
|
August 1, 2012
Pentraxin 3 (PTX3) inhibits plasma cell/stromal cell cross-talk in the bone marrow of multiple myeloma patients
Antonio Basile, Michele Moschetta, Paolo Ditonno, et al.
Haematologica
|
November 8, 2011
Salvage treatment with lenalidomide and dexamethasone in relapsed/refractory mantle cell lymphoma: clinical results and effects on microenvironment and neo-angiogenic biomarkers
Francesco Zaja, Stefano De Luca, Umberto Vitolo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 4, 2013
HIF-1α of bone marrow endothelial cells implies relapse and drug resistance in patients with multiple myeloma and may act as a therapeutic target
Roberto Ria, Ivana Catacchio, Simona Berardi, et al.
Neoplasia (New York, N.Y.)
|
December 12, 2018
Homotypic and Heterotypic Activation of the Notch Pathway in Multiple Myeloma-Enhanced Angiogenesis: A Novel Therapeutic Target?
Ilaria Saltarella, Maria Antonia Frassanito, Aurelia Lamanuzzi, et al.
Frontiers in Medicine
|
February 8, 2021
Short-Term Variations in Neutrophil-to-Lymphocyte and Urea-to-Creatinine Ratios Anticipate Intensive Care Unit Admission of COVID-19 Patients in the Emergency Department
Antonio Giovanni Solimando, Nicola Susca, Paola Borrelli, et al.
Blood
|
January 14, 2011
Complete response correlates with long-term progression-free and overall survival in elderly myeloma treated with novel agents: analysis of 1175 patients
Francesca Gay, Alessandra Larocca, Pierre Wijermans, et al.
Page
of 14
Search research articles
Search
Showing results (101-110 of 137) with videos related to
Sort By:
Page
of 14
The Journal of Pathology
|
December 17, 2021
Myeloma cells regulate miRNA transfer from fibroblast-derived exosomes by expression of lncRNAs
Ilaria Saltarella, Aurelia Lamanuzzi, Vanessa Desantis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 28, 2013
Novel targeting of phospho-cMET overcomes drug resistance and induces antitumor activity in multiple myeloma
Michele Moschetta, Antonio Basile, Arianna Ferrucci, et al.
Frontiers in Medicine
|
June 2, 2022
Cardiovascular Risk in Patients With Takayasu Arteritis Directly Correlates With Diastolic Dysfunction and Inflammatory Cell Infiltration in the Vessel Wall: A Clinical, <i>ex vivo</i> and <i>in vitro</i> Analysis
Sebastiano Cicco, Vanessa Desantis, Antonio Vacca, et al.
Blood
|
May 29, 2008
Oral melphalan, prednisone, and thalidomide in elderly patients with multiple myeloma: updated results of a randomized controlled trial
Antonio Palumbo, Sara Bringhen, Anna M Liberati, et al.
The Journal of Pathology
|
August 1, 2012
Pentraxin 3 (PTX3) inhibits plasma cell/stromal cell cross-talk in the bone marrow of multiple myeloma patients
Antonio Basile, Michele Moschetta, Paolo Ditonno, et al.
Haematologica
|
November 8, 2011
Salvage treatment with lenalidomide and dexamethasone in relapsed/refractory mantle cell lymphoma: clinical results and effects on microenvironment and neo-angiogenic biomarkers
Francesco Zaja, Stefano De Luca, Umberto Vitolo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 4, 2013
HIF-1α of bone marrow endothelial cells implies relapse and drug resistance in patients with multiple myeloma and may act as a therapeutic target
Roberto Ria, Ivana Catacchio, Simona Berardi, et al.
Neoplasia (New York, N.Y.)
|
December 12, 2018
Homotypic and Heterotypic Activation of the Notch Pathway in Multiple Myeloma-Enhanced Angiogenesis: A Novel Therapeutic Target?
Ilaria Saltarella, Maria Antonia Frassanito, Aurelia Lamanuzzi, et al.
Frontiers in Medicine
|
February 8, 2021
Short-Term Variations in Neutrophil-to-Lymphocyte and Urea-to-Creatinine Ratios Anticipate Intensive Care Unit Admission of COVID-19 Patients in the Emergency Department
Antonio Giovanni Solimando, Nicola Susca, Paola Borrelli, et al.
Blood
|
January 14, 2011
Complete response correlates with long-term progression-free and overall survival in elderly myeloma treated with novel agents: analysis of 1175 patients
Francesca Gay, Alessandra Larocca, Pierre Wijermans, et al.
Page
of 14